Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03001843 · ClinicalTrials.gov registry record · Phase 4
Ketamine vs Hydromorphone
A Phase 4 study, sponsored by University of Florida.
- Completed
- Registry status
- Phase 4
- Development phase
- 54
- Enrollment target
NCT03001843 is a Phase 4 study that has completed, run by University of Florida. The registered enrollment target is 54 participants.
The verdict
NCT03001843, a Phase 4 study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 54 participants
- Enrollment target
Study Summary
This study will help to determine if investigators can minimize narcotic use in laparoscopic gastric bypass patients while maintaining adequate pain control. This will allow investigators to minimize the negative side effects of narcotics which is a goal in this population.
Interventions
- DRUG Ketamine
- DRUG Narcotics
- BEHAVIORAL pain scale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2017-02-22 |
| Est. Completion | 2018-12-21 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03001843
The ClinicalTrials.gov registry entry for NCT03001843 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Ketamine is the first listed.
NCT03001843 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03001843 about?
NCT03001843 is a clinical study titled "Ketamine vs Hydromorphone". This study will help to determine if investigators can minimize narcotic use in laparoscopic gastric bypass patients while maintaining adequate pain control. This will allow investigators to minimize the negative side effects of narcotics which is a goal in this population.
What is the current status of trial NCT03001843?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 54 participants. The study started on 2017-02-22. Estimated completion is 2018-12-21.
What interventions are being tested in trial NCT03001843?
The interventions under investigation include: Ketamine (DRUG), Narcotics (DRUG), pain scale (BEHAVIORAL).
Who is sponsoring clinical trial NCT03001843?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.